Source - RNS
RNS Number : 4638T
Dechra Pharmaceuticals PLC
12 October 2017
 



 

 

 

12 October 2017

 

Dechra® Pharmaceuticals PLC

(Dechra or the Company)

LEI: 213800J4UVB5OWG8VX82

 

Notification and public disclosure of transactions by

persons discharging managerial responsibilities (PDMRs)

 

 

 

Grant of SAYE options:

 

Dechra Pharmaceuticals PLC announces that today the following PDMRs were granted options over ordinary shares of 1p each in the Company pursuant to the Dechra Pharmaceuticals Save As You Earn Scheme (the Options).

 

The Options have been granted with an exercise price of £16.46.

 

 

Name

Capacity

Options Granted

Ian Page

Director

1,093

Richard Cotton

Director

1,093

 

 

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

 

Notification of Dealing Form

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Ian Page

 

2.

Reason for the notification

a)

Position/status

Director/PDMR

 

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Dechra Pharmaceuticals PLC

b)

LEI code

213800J4UVB5OWG8VX82

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary Shares of 1 pence each

 

 

ISIN: GB0009633180

b)

Nature of the transaction

Grant of 1,093 options under the Company's Save As You Earn Scheme

c)

Price(s) and volumes(s)

Price(s)

£16.46

Volume(s)

1,093

d)

Aggregated information

-   Aggregate volume

-   Price

 

 

1,093

£17,990.78

e)

Date of the transaction

2017.10.12

f)

Place of the transaction

Outside a trading venue

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Richard Cotton

 

2.

Reason for the notification

a)

Position/status

Director/PDMR

 

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Dechra Pharmaceuticals PLC

b)

LEI code

213800J4UVB5OWG8VX82

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary Shares of 1 pence each

 

 

ISIN: GB0009633180

b)

Nature of the transaction

Grant of 1,093 options under the Company's Save As You Earn Scheme

c)

Price(s) and volumes(s)

Price(s)

£16.46

Volume(s)

1,093

d)

Aggregated information

-   Aggregate volume

-   Price

 

 

1,093

£17,990.78

e)

Date of the transaction

2017.10.12

f)

Place of the transaction

Outside a trading venue

 

 

For further information, please contact:

 

Melanie Hall, Company Secretary                         

Telephone number: 01606 814730

 

 

 

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

 

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKBDDDBDDQKD

Related Charts

Dechra Pharmaceuticals (DPH)

-26.00p (-1.25%)
delayed 15:11PM